Nordic Group And Taiho Pharmaceutical Co. Ltd

Taiho Pharmaceutical Co., Ltd and Nordic Group BV Enter Into a Development and Commercialization Agreement for the Recently EMA Approved Anti-Cancer Drug Teysuno[TM] Covering the EU and Other Selected European Countries

PARIS, July 21, 2011 - Taiho Pharmaceutical Co., Ltd.